The metabolic adaptations that defend higher body weight return when medication support ends
Recent research has broadened its applications beyond HSDD, highlighting its synergistic potential with HRT during perimenopause and menopause for comprehensive sexual health benefits.[6][7] This evidence prompted HyperCharge Health centers across the nation to incorporate PT-141 protocols, particularly for women over 40, where up to 40% report low desire due to hormonal shifts.[5][8] At our clinics, we've observed patients not only regaining libido but also experiencing less pain and greater emotional connection in intimacy after integrating PT-141 with other therapies
Additionally, semaglutide acts on appetite-regulating centers in the brain, promoting satiety and reducing caloric intake, which facilitates weight loss
When medications are studied, researchers look for how they might interact with each other
IR: Conceptualization, Funding acquisition, Project administration, Writing original draft, Writing review & editing